GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » National Health Investors Inc (NYSE:NHI) » Definitions » Sloan Ratio %

National Health Investors (National Health Investors) Sloan Ratio % : -1.49% (As of Dec. 2023)


View and export this data going back to 1991. Start your Free Trial

What is National Health Investors Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

National Health Investors's Sloan Ratio for the quarter that ended in Dec. 2023 was -1.49%.

As of Dec. 2023, National Health Investors has a Sloan Ratio of -1.49%, indicating the company is in the safe zone and there is no funny business with accruals.


National Health Investors Sloan Ratio % Historical Data

The historical data trend for National Health Investors's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Health Investors Sloan Ratio % Chart

National Health Investors Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.61 1.37 -10.02 -12.64 -1.49

National Health Investors Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.64 -10.17 -2.90 -0.36 -1.49

Competitive Comparison of National Health Investors's Sloan Ratio %

For the REIT - Healthcare Facilities subindustry, National Health Investors's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


National Health Investors's Sloan Ratio % Distribution in the REITs Industry

For the REITs industry and Real Estate sector, National Health Investors's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where National Health Investors's Sloan Ratio % falls into.



National Health Investors Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

National Health Investors's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(135.654-184.45
--11.63)/2488.48
=-1.49%

National Health Investors's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(135.655-184.45
--11.63)/2488.48
=-1.49%

National Health Investors's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 34.484 (Mar. 2023 ) + 39.779 (Jun. 2023 ) + 29.346 (Sep. 2023 ) + 32.046 (Dec. 2023 ) = $135.7 Mil.
National Health Investors's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 31.048 (Mar. 2023 ) + 50.496 (Jun. 2023 ) + 49.703 (Sep. 2023 ) + 53.203 (Dec. 2023 ) = $184.5 Mil.
National Health Investors's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -27.521 (Mar. 2023 ) + 33.501 (Jun. 2023 ) + -19.946 (Sep. 2023 ) + 2.336 (Dec. 2023 ) = $-11.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


National Health Investors  (NYSE:NHI) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, National Health Investors has a Sloan Ratio of -1.49%, indicating the company is in the safe zone and there is no funny business with accruals.


National Health Investors Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of National Health Investors's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


National Health Investors (National Health Investors) Business Description

Traded in Other Exchanges
Address
222 Robert Rose Drive, Murfreesboro, TN, USA, 37129
National Health Investors Inc is a housing and medical facility REIT. The company operate through two reportable segments i.e. Real Estate Investments and Senior Housing Operating Portfolio. Real Estate Investments segment consists of real estate investments and lease, mortgage and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. SHOP segment is comprised of two ventures that own the operations of independent living facilities. Company's revenues are derived from rental income, mortgage and other notes receivable interest income and resident fees and services.
Executives
James R Jobe director 707 REGAL DRIVE, MURFREESBORO TN 37129
Robert G Adams director, officer: President P.O. BOX 1398, MURFREESBORO TN 37133-1398
Colden Tracy M J director C/O PLAYA HOTELS & RESORTS N.V.,, 3950 UNIVERSITY DRIVE, SUITE 301, FAIRFAX VA 22030
Robert T Webb director PO BOX 1102, MURFREESBORO TN 37133-1102
D. Eric Mendelsohn officer: EVP - Corporate Finance C/O EMERITUS CORPORATION, 3131 ELLIOTT AVENUE, SUITE 500, SEATTLE WA 98121
Mccabe Robert A Jr director 500 CHURCH ST, STE 200, NASHVILLE TN 37219
David L Travis officer: SVP/Chief Accounting Officer C/O MEDEQUITIES REALTY TRUST, 3100 WEST END AVENUE, SUITE 1000, NASHVILLE TN 37203
W Andrew Adams director, officer: President P.O. BOX 1398, MURFREESBORO TN 37133-1398
Kevin Carlton Pascoe officer: EVP - Investments 222 ROBERT ROSE DRIVE, MURFREESBORO TN 37129
Ronald V Reel officer: Chief Accounting Officer 222 ROBERT ROSE DRIVE, MURFREESBORO TN 37129
Kristin Sallee Gaines officer: Chief Credit Officer 2320 LONDONDERRY DRIVE, MURFREESBORO TN 37129
John L Spaid officer: Exec. VP of Finance 222 ROBERT ROSE DRIVE, MURFREESBORO TN 37129
Roger R Hopkins officer: Chief Accounting Officer 2930 PRINCETON LANE, MURFREESBORO TN 37129
James Justin Hutchens officer: President and COO C/O VENTAS, INC., 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Ted H Welch director PO BOX 1102, MURFREESBORO TN 37133-1102

National Health Investors (National Health Investors) Headlines

From GuruFocus

NHI Issues Investor Update

By ACCESSWIRE 08-09-2023

NHI Announces $200 Million Term Loan

By ACCESSWIRE ACCESSWIRE 06-21-2023

NHI Provides Business Update

By ACCESSWIRE ACCESSWIRE 04-04-2022

NHI Provides Business Update

By ACCESSWIRE ACCESSWIRE 06-07-2022

NHI Announces Second Quarter 2023 Dividend

By ACCESSWIRE ACCESSWIRE 05-10-2023

NHI Issues Investor Update

By ACCESSWIRE ACCESSWIRE 05-10-2023

NHI Announces Third Quarter 2023 Dividend

By ACCESSWIRE 08-09-2023